Cargando…
Management of delayed encephalopathy after CO poisoning: An evidence-based narrative review
BACKGROUND: Approximately 10% to 30% patients develop delayed encephalopathy after acute CO poisoning (DEACMP). No specific treatment is available and poor prognosis is a characteristic of this disease. We aimed to evaluate the efficacy and safety of all therapies that have been tried in randomized...
Autores principales: | Xu, Xiao-Min, Luo, Hua, Rong, Ben-bing, Zheng, Xiao-Mei, Wang, Feng-tao, Zhang, Shu-Jiang, Li, Zuo-Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6919536/ https://www.ncbi.nlm.nih.gov/pubmed/31804341 http://dx.doi.org/10.1097/MD.0000000000018199 |
Ejemplares similares
-
Nonpharmacological therapies for central poststroke pain: A systematic review
por: Xu, Xiao-Min, et al.
Publicado: (2020) -
Misdiagnosed centipede and scorpion poisoning characterized by delayed hypersensitivity reaction: A case report
por: Li, Yaxin, et al.
Publicado: (2022) -
Effects of the non-pharmacological interventions of traditional Chinese medicine on postpartum depression: A protocol for systematic review and network meta-analysis
por: Huang, XiaoMei, et al.
Publicado: (2022) -
Buzhong Tiaogan Formula for delaying colorectal liver metastasis (liver depression spleen deficient type): A multicenter randomized controlled trial: A study protocol
por: Wang, Zhi-Jie, et al.
Publicado: (2021) -
Efficacy and safety of puerarin injection in curing acute ischemic stroke: A meta-analysis of randomized controlled trials
por: Zheng, Qing-Hua, et al.
Publicado: (2017)